How did the 'killer batch' of cough syrup evade detection?

The batch moved through the entire supply chain, including procurement, manufacturing, and distribution, without being stopped due to a continuous chain of failures and gaps.

What issues were identified in the manufacturing and distribution of Coldrif cough syrup?

Investigators noted the sourcing of industrial-grade material, inadequate testing facilities, and irregularities at stockist and retail levels, such as missing bottles and mismatched invoices.

What led to the deaths of children associated with Batch SR-13?

Batch SR-13 of the cough syrup Coldrif was responsible for the deaths of over 25 children in Chhindwara due to alleged toxicity from contaminants like Diethylene Glycol.

Home / Crime and Justice / Killer Cough Syrup Batch Evaded All Checks

Killer Cough Syrup Batch Evaded All Checks

14 Feb

•

Summary

A 'killer batch' of cough syrup moved unchecked through the supply chain.
Industrial-grade material was allegedly sourced for the syrup.
Testing gaps and distribution irregularities allowed the syrup to circulate.

Killer Cough Syrup Batch Evaded All Checks

Batch SR-13 of the cough syrup Coldrif, implicated in the deaths of over 25 children in Chhindwara, Madhya Pradesh, was found to have moved unimpeded through the entire supply chain. Investigators highlighted a "continuous and interlinked chain" of lapses, from raw material procurement to retail sales. The chargesheet revealed that industrial-grade material was allegedly sourced by Sresun Pharma, with financial transactions lacking transparency. Crucially, the company reportedly lacked adequate testing facilities, including gas chromatography, to detect dangerous contaminants like Diethylene Glycol (DEG).

Despite these deficiencies, Batch SR-13 was cleared and entered the distribution network. Irregularities at stockist and retail levels, including mismatched invoices and missing bottles, were noted. The investigation identified a critical juncture when unusual kidney injury cases emerged, prompting a discussion between a doctor and an expert about drug-induced toxicity, referencing past DEG tragedies. However, no immediate regulatory action followed, and the syrup remained in circulation.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.